Cargando…
Development and regulation of stem cell‐based therapies in China
BACKGROUND: Clinical researches of stem cell‐based therapies are highly active in China, while it was arduous to determine the most effective way of clinical translation of those advanced therapies. METHODS: This article briefly introduced the regulatory framework development, the progress in stem c...
Autores principales: | Gao, Jianchao, Gao, Chenyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357352/ https://www.ncbi.nlm.nih.gov/pubmed/35419811 http://dx.doi.org/10.1111/cpr.13217 |
Ejemplares similares
-
Gene and cell therapies in China: booming landscape under dual-track regulation
por: Yin, Chen, et al.
Publicado: (2022) -
Development of stem cell-based therapy for Parkinson’s disease
por: Han, Fabin, et al.
Publicado: (2015) -
Current Development Status of Forest Therapy in China
por: Zhang, Zhiyong, et al.
Publicado: (2020) -
Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges
por: Gao, Yiyin, et al.
Publicado: (2021) -
Stem Cell-Based Therapies for Inflammatory Bowel Disease
por: Zhang, Hua-Min, et al.
Publicado: (2022)